MagForce Nanotechnologies AG reaches primary study endpoint in pivotal glioblastoma study (Business Wire via Yahoo! Finance)

BERLIN—-MagForce Nanotechnologies AG has successfully completed its single-arm clinical trial on the efficacy of thermotherapy using superparamagnetic nanoparticles in patients with recurrent glioblastoma.
(read the story…)

Related items

• MagForce Nanotechnologies completes clinical trial of Nano-Cancer therapy in glioblastoma patients (News-Medical-Net)
• MagForce Nanotechnologies Completes Patient Recruitment for Pivotal Glioblastoma Study (Business Wire via Yahoo! Finance)
• Swallowing the doctor (Independent Online)
• MagForce Nanotechnologies AG appoints Dr. Peter Heinrich as Chief Executive Officer (Business Wire via Yahoo! Finance)
• Nanostart-Owned MagForce Nanotechnologies AG: Application Submitted For EU Regulatory Approval Of Nano-Cancer(R) Therapy (Medical News Today)

Tags: BERLIN----MagForce, efficacy, magforce, magnetic nanoparticles, nano, nanoparticle, nanoparticles, nanotech, nanotechnologie, nanotechnologies, recurrent glioblastoma, thermotherapy, trial

This entry was posted on Wednesday, November 4th, 2009 at 1:53 am and is filed under Business.